Wires

Pfizer says pain drug as safe as rival pills in trial

Share

Oct 11 (Reuters) - Pfizer Inc said a late-stagetrial of its experimental pain drug showed the drug's long-termsafety profile was comparable to those of other similarformulations.

The trial was testing the safety of the drug, called ALO-02,when administered for up to 12 months.

The drug uses a technology that discourages common methodsof drug abuse associated with prescription opioid use.

(Reporting by Esha Dey in Bangalore; Editing by SreejirajEluvangal)

((esha.dey@thomsonreuters.com)(within U.S. +1 646 223 8780,outside U.S. +91 80 4135 5800)(Reuters Messaging:esha.dey.thomsonreuters.com@reuters.net))

Keywords: PFIZER TRIAL PAINDRUG/